Entero Therapeutics Inc (ENTO)
0.4533
+0.04
(+9.23%)
USD |
NASDAQ |
Nov 22, 16:00
0.4433
-0.01
(-2.21%)
After-Hours: 20:00
Entero Therapeutics Shareholders Equity (Quarterly): 70.05M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 70.05M |
| June 30, 2024 | 70.80M |
| March 31, 2024 | 77.86M |
| December 31, 2023 | 3.603M |
| September 30, 2023 | 3.279M |
| June 30, 2023 | 0.882M |
| March 31, 2023 | 2.713M |
| December 31, 2022 | 2.742M |
| September 30, 2022 | -2.28M |
| June 30, 2022 | -14.19M |
| March 31, 2022 | -9.240M |
| December 31, 2021 | -7.822M |
| September 30, 2021 | -6.97M |
| June 30, 2021 | 7.037M |
| March 31, 2021 | 14.40M |
| December 31, 2020 | -2.641M |
| September 30, 2020 | 14.07M |
| June 30, 2020 | -0.7974M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.041M |
| December 31, 2019 | 4.617M |
| September 30, 2019 | 3.202M |
| June 30, 2019 | 2.948M |
| March 31, 2019 | 2.713M |
| December 31, 2018 | 4.474M |
| September 30, 2018 | 5.532M |
| June 30, 2018 | 7.628M |
| March 31, 2018 | 1.098M |
| December 31, 2017 | 1.661M |
| September 30, 2017 | 2.796M |
| June 30, 2017 | 4.645M |
| March 31, 2017 | 1.471M |
| December 31, 2016 | 3.213M |
| September 30, 2016 | -12.37M |
| June 30, 2016 | -9.235M |
| March 31, 2016 | -5.420M |
| December 31, 2015 | -3.630M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-14.19M
Minimum
Jun 2022
77.86M
Maximum
Mar 2024
11.56M
Average
2.892M
Median
Shareholders Equity (Quarterly) Benchmarks
| Pulmatrix Inc | 10.92M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 85.82M |
| Total Liabilities (Quarterly) | 15.77M |